Drug Stocks McKesson, AmerisourceBergen Pop On Reports Of $26 Billion Settlement In Opioid Fight

Drug stocks popped Tuesday on reports they could pay $21 billion to settle claims they helped fuel the nation’s opioid epidemic.
Read More